Dockendorff has been the finance chief at Mansfield, Mass.-based Covidien since 1995.
Early this year Dockendorff announced plans to step down at the end of 2014 after a 25-year run in the companies that evolved into Covidien. He joined Kendall Healthcare Products, the foundation of Covidien formerly known as Tyco Healthcare, in 1989 as controller and was named vice president and controller in 1994, according to a press release.
"Chuck is a highly-respected healthcare industry leader. He brings an extensive financial management and planning background to our board, along with considerable experience with one of the world’s premier healthcare products companies. His contributions will help to guide the company as it seeks to grow market share and provide industry leading returns to shareholders,"Haemonetics chairman Richard Meelia– himself a Covidien veteran who retired as CEO in 2011 – said in prepared remarks.
"Blood management is a key element of the health care continuum globally, as patient care advances and the focus on reducing costs continues to be a priority. Haemonetics is very well positioned with solutions to help our collection and hospital customers address these opportunities," Dockendorff added. "I look forward to joining the Board of Directors and serving the company’s shareholders."
Haemonetics also said that Paul Black resigned from its board effective July 31, "based on his desire to focus more of his time in his role" as president & CEO of Allscripts (NSDQ:MDRX)," according to a regulatory filing.
Invacare CEO Blouch to retire
said president & CEO Gerald Blouch is slated to retire July 31, succeeded on an interim basis by CFO Robert Gudbranson while the company searches for a permanent replacement.
VirtualScopics makes interim CEO Converse permanent
VirtualScopics (NSDQ:VSCP) said last week that it named Eric Converse, interim president & CEO for the past 9 months, as its permanent chief executive.
MDSave taps Stryker, Boston Scientific vet Magee
MDSave said it named former Stryker (NYSE:SYK) and Boston Scientific (NYSE:BSX) sales manager Calvin Magee as its new executive vice president and named Magee to its board of directors.
Feldbaum replaces Burrill as Life Sciences Foundation chairman
The Life Sciences Foundation said it appointed Carl Feldbaum as its new interim chairman, replacing prominent venture capitalist Stephen Burrill, who helped form the organization. Burrill is under a cloud after the manager of 1 of his funds allegedly discovered that he and his company’s chief counsel and its CFO misappropriated nearly $20 million from the fund.
- Ex-Elan CFO Clerkin is the new finance chief at ConvaTec
- Philips Healthcare names new South Asia president
- Oncologix names Halman COO of new American Medical Products business
- BSD Medical names Hologic vet Leahy as new training director
- Multiple myeloma Dx forces Schiro to resign from Philips, Reva Medical boards